UBS Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,402
| Closed | -$11.6K | – | 9260 |
|
|
2024
Q3 | $11.6K | Buy |
+3,402
| New | +$11.6K | ﹤0.01% | 6461 |
|
|
2024
Q2 | – | Sell |
-101
| Closed | -$748 | – | 8934 |
|
|
2024
Q1 | $748 | Buy |
101
+77
| +321% | +$570 | ﹤0.01% | 7206 |
|
|
2023
Q4 | $225 | Sell |
24
-877
| -97% | -$8.22K | ﹤0.01% | 7576 |
|
|
2023
Q3 | $14.2K | Buy |
+901
| New | +$14.2K | ﹤0.01% | 5825 |
|
|
2023
Q2 | – | Sell |
-78
| Closed | -$6.53K | – | 7552 |
|
|
2023
Q1 | $6.53K | Buy |
78
+68
| +680% | +$5.7K | ﹤0.01% | 6813 |
|
|
2022
Q4 | $1.38K | Buy |
+10
| New | +$1.38K | ﹤0.01% | 8684 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 9745 |
|
|
2021
Q4 | $0 | Sell |
1
-26
| -96% | – | ﹤0.01% | 9513 |
|
|
2021
Q3 | $12K | Buy |
27
+9
| +50% | +$4K | ﹤0.01% | 6657 |
|
|
2021
Q2 | $10K | Sell |
18
-119
| -87% | -$66.1K | ﹤0.01% | 6965 |
|
|
2021
Q1 | $86K | Buy |
+137
| New | +$86K | ﹤0.01% | 5090 |
|
|
2020
Q3 | – | Sell |
-9
| Closed | -$7K | – | 7461 |
|
|
2020
Q2 | $7K | Buy |
9
+7
| +350% | +$5.44K | ﹤0.01% | 6382 |
|
|
2020
Q1 | $1K | Sell |
2
-8
| -80% | -$4K | ﹤0.01% | 6894 |
|
|
2019
Q4 | $11K | Sell |
10
-1
| -9% | -$1.1K | ﹤0.01% | 6176 |
|
|
2019
Q3 | $17K | Buy |
+11
| New | +$17K | ﹤0.01% | 5878 |
|
|
2019
Q2 | – | Sell |
-11
| Closed | -$12K | – | 7188 |
|
|
2019
Q1 | $12K | Buy |
11
+1
| +10% | +$1.09K | ﹤0.01% | 5866 |
|
|
2018
Q4 | $7K | Buy |
10
+7
| +233% | +$4.9K | ﹤0.01% | 6500 |
|
|
2018
Q3 | $5K | Buy |
+3
| New | +$5K | ﹤0.01% | 6591 |
|